Amorphous object of cinnamide compound
US7923563B2 · kind B2 · utility
16Cited by
16References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2005 |
| Grant date | Apr 12, 2011 |
| Priority date | — |
| Expiry date | Jul 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An amorphous object of (3E)-1-[l(s)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by the formula (1) and has Aβ-production inhibitory activity. The amorphous object has such satisfactory properties that it has excellent solubility, is stable, does not readily become a crystalline form, and has low hygroscopicity. It is hence suitable for use in pharmaceutical preparations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.